IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (9)
Stifel
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 | 908 Devices Inc | Health-Care | 20 | 6 | COWN | LRNK | Stifel | 64.9% | 145% | ||
| Dec 11 | AbCellera Biolo | Health-Care | 20 | 24 | CS | Stifel | BMO | 38.3% | 194.5% | ||
| Dec 10 | Hydrofarm Holdi | Basic-Industries | 20 | 8 | JPM | Stifel | DB | 76.5% | 160% | ||
| Dec 4 | Silverback Ther | Health-Care | 21 | 11 | GS | LRNK | Stifel | 31% | 19% | ||
| Nov 19 | NeoGames S.A. | Consumer-Services | 17 | 4 | Stifel | 57.3% | 28.6% | ||||
| Oct 30 | SQZ Biotechnolo | Health-Care | 16 | 4 | BAML | EVCR | Stifel | 19.2% | -17.2% | ||
| Sep 18 | Athira Pharma I | Health-Care | 17 | 12 | GS | JEFF | Stifel | 26.8% | 0.6% | ||
| Jul 24 | Nurix Therapeut | Health-Care | 19 | 11 | JPM | SNDL | Stifel | 21.4% | 0.3% | ||
| Jul 10 | Nkarta Inc. | Health-Care | 18 | 14 | COWN | EVCR | Stifel | 9.4% | 166.1% | ||
*
Lead manager or one of top three managers in an underwriting team.